522 Results

People

  1. De Angelis
    De Angelis
  2. Kris
    Kris
  3. Motzer
    Motzer
  4. Livingston
    Livingston
  5. Aghajanian
    Aghajanian
  6. Krown
    Krown
  7. Panageas
    Panageas
  8. Miller
    Miller
  9. Tyson
    Tyson
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)
  7. Tow Center for Developmental Oncology (TCDO) (51)
  8. Epidemiology and Biostatistics (49)
  9. Population Sciences Research Program (45)
  10. Genitourinary Oncology Service (41)
  1. "headache"
Formats
  1. Journal Article (491)
  2. Review (17)
  3. Research Letter (5)
  4. Conference Paper (3)
  5. Editorial (3)
  6. Book Whole (1)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)

More Groups

People
  1. Lisa De Angelis (20)
  2. Mark Kris (20)
  3. Robert Motzer (19)
  4. Philip Livingston (13)
  5. Carol Aghajanian (12)
  6. Katherine Panageas (12)

More People

Years
  1. 2025 (15)
  2. 2024 (34)
  3. 2023 (30)
  4. 2022 (16)
  5. 2021 (18)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (23)
  3. Lancet Oncology (20)
  4. Blood (18)
  5. New England Journal of Medicine (17)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Elsevier Science, Inc. (43)
  3. Springer (42)
  4. American Society of Clinical Oncology (37)
  5. Nature Publishing Group (32)
  6. Oxford University Press (29)

More Publishers

Results (522)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
    Journal Article

    Voss, M. H.; Hussain, A.; Vogelzang, N.; Lee, J. L.; Keam, B.; Rha, S. Y.; Vaishampayan, U.; Harris, W. B.; Richey, S.; Randall, J. M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Treatment of gastrointestinal stromal tumours in paediatric and young adult patients with sunitinib: A multicentre case series
    Journal Article

    Rutkowski, P.; Magnan, H.; Chou, A. J.; Benson, C.
    BMC Cancer (2017)

    Fulltext@MSK | Save
  • Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Journal Article

    Kim, S. B.; Dent, R.; Im, S. A.; Espié, M.; Blau, S.; Tan, A. R.; Isakoff, S. J.; Oliveira, M.; Saura, C.; Wongchenko, M. J.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save
  • Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression
    Journal Article

    Lopez, G. Y.; Oberheim Bush, N. A.; Phillips, J. J.; Bouffard, J. P.; Moshel, Y. A.; Jaeckle, K.; Kleinschmidt-DeMasters, B. K.; Rosenblum, M. K.; Perry, A.; Solomon, D. A.
    Acta Neuropathologica (2017)

    Fulltext@MSK | Save
  • Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: Case report
    Journal Article

    Ivasyk, I.; Morgenstern, P. F.; Wembacher-Schroeder, E.; Souweidane, M. M.
    Journal of Neurosurgery-Pediatrics (2017)

    Fulltext@MSK | Save
  • Anthracyclines in early breast cancer: The ABC trials - USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
    Journal Article

    Blum, J. L.; Flynn, P. J.; Yothers, G.; Asmar, L.; Geyer, C. E., Jr.; Jacobs, S. A.; Robert, N. J.; Hopkins, J. O.; O’Shaughnessy, J. A.; Dang, C. T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitor treatment for newly diagnosed chronic myeloid leukemia
    Journal Article

    Radich, J. P.; Mauro, M. J.
    Hematology/Oncology Clinics of North America (2017)

    Fulltext@MSK | Save
  • A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
    Journal Article

    Martin, T.; Baz, R.; Benson, D. M.; Lendvai, N.; Wolf, J.; Munster, P.; Lesokhin, A. M.; Wack, C.; Charpentier, E.; Campana, F.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
    Journal Article

    LoRusso, P. M.; Gounder, M.; Jalal, S. I.; André, V.; Kambhampati, S. R. P.; Loizos, N.; Hall, J.; Holzer, T. R.; Nasir, A.; Cosaert, J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A single-arm, multicentre, phase 2 trial
    Journal Article

    Balar, A. V.; Galsky, M. D.; Rosenberg, J. E.; Powles, T.; Petrylak, D. P.; Bellmunt, J.; Loriot, Y.; Necchi, A.; Hoffman-Censits, J.; Perez-Gracia, J. L.; more...
    Lancet (2017)

    Fulltext@MSK | Save